Axitinib Drug Information
A healthcare provider may prescribe axitinib (Inlyta®) to help slow down the progression of a certain type of kidney cancer called advanced renal cell carcinoma. It is approved specifically for adults who have tried at least one other chemotherapy medication, but without success.
Axitinib works by blocking certain receptors found on the surface of cancer cells. By blocking these receptors, axitinib slows down the growth and spread of cancer cells. Although some people do not experience any problems with axitinib, most people will develop some type of side effect, such as nausea, fatigue, or diarrhea.
While it may be an effective form of chemotherapy, not everyone can use this drug. Information on axitinib should be reviewed with your healthcare provider to help ensure a safe treatment. For instance, you may not be able to use axitinib if you are taking certain medications or have certain allergies.
(Click Axitinib for more details on this drug, including information on what your healthcare provider needs to know before you start treatment and why this chemotherapy medicine may not be the best choice for some people.)